Pharma risk-sharing scheme a 'costly failure'

A trial project to provide patients with information to make better treatment decisions has been launched by NHS Direct.

A risk-sharing agreement between the government and drug companies to supply expensive multiple sclerosis medicines was a “costly failure”, experts have claimed.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here